Yakira Capital Management’s Elevation Oncology ELEV Stock Holding History

Yakira Capital Management’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-263,097	Closed	-$96.6K	–	199
2025 Q2	$96.6K	Buy	+263,097	New	+$87.8K	0.03%	123

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Yakira Capital Management's ELEV Position: Q3 2025 in Review

Yakira Capital Management sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 263,097 shares — an estimated $96.6K sold.

Yakira Capital Management first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $96.6K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Yakira Capital Management reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Yakira Capital Management sold 263,097 Elevation Oncology shares in Q3 2025, an estimated $96.6K.
Yakira Capital Management first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
Yakira Capital Management's Elevation Oncology position peaked at $96.6K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Yakira Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.